The report will be delivered in 2-3 business days.

Cancer Diagnostics Global Market Report 2019

Starting Price : $ 4000.00 | Pages : 200 | Published : December 2019 | SKU CODE : 7198 | Format :


The cancer diagnostics market consists of sales of cancer diagnostic devices and equipment. Cancer diagnostic equipment is used to identify biomarkers, proteins and symptoms in order to detect a cancerous tumor in the patient. Cancer diagnostics market is segmented into companion diagnostics and molecular diagnostics.

The global cancer diagnostics market was valued at about $145.53 billion in 2018 and is expected to grow to $211.53 billion at a CAGR of 9.8% through 2022.

North America was the largest region in the cancer diagnostics market in 2018. This region is expected to remain the largest during the next five years. The cancer diagnostics market in Asia Pacific is forecasted to register the highest CAGR during 2018-2023.

A high prevalence rate of various types of cancers is a major driver of the cancer diagnostics market. This is because the increasing incidences of various types of cancers is leading to more number of people opting for diagnosis and treatment. For instance, according to the World Cancer Research Fund (WCRF), in 2018, the number of cancer cases worldwide was approximately 18 million, out of which, 9.5 million cases were diagnosed in men and 8.5 million in women. In addition, according to the World Health Organization (WHO), cancer was the second-leading cause of death worldwide, responsible for approximately 9.6 million deaths in 2018. The National Cancer Insititute (NCI) has estimated the number of new cancer cases per year to reach 23.6 million by 2030.

Product recall is one of the major restraints for the cancer diagnostics market. Product recall is a process of retrieving all faulty and defective products that have been sold or are available in the market. When a company recalls a product from the market, it takes up the cost of fixing the defective product and replacing it. This cost of replacement of cancer diagnostics devices can be very high for manufacturers, which ultimately restricts the growth of the market. For example, in 2016, Siemens Healthcare Diagnostics had to recall its IMMULITE/IMMULITE 1000 Systems Prostate-Specific Antigen (PSA) Assay as it was not meeting the required high-dose hook effect expectation. An IMMULITE/IMMULITE 1000 Systems Prostate-Specific Antigen (PSA) Assay can be used as an aid in the detection of prostate cancer along with digital rectal examination (DRE) in men aged 50 years or older.

AI-based cancer detection system is an emerging trend in the cancer diagnostics market. AI helps in improving the accuracy of image detection in diagnostic processes such as breast cancer and lung cancer diagnostics, by detecting the cancers in early stages. AI also reduces the instances of false positives in lung cancer screening, thus, improving the lung cancer detection accuracy. For instance, in 2018, researchers at the Naval Medical Center San Diego and Google's AI research division Google AI, developed a reliable solution comprised of cancer-detecting algorithms used for autonomous evaluation of lymph node biopsies. This AI solution improved the accuracy of metastatic breast cancer detection to 99%.

The cancer diagnostics market is regulated by the FDA which imposes restrictions on cancer diagnostic devices such as magnetic resonance imaging (MRI) and nuclear magnetic resonance spectroscopy (NMR). The FDA categorizes these devices into class II category, as they have a moderate risk associated with usage. Class II devices are bounded by device specific regulations which include performance standards, premarket data requirements, postmarket surveillance and labelling requirements associated with their usage. For instance, the labelling of such devices is required to have a list of contraindications, adverse reactions, precautions, warnings and other instructions before being released in the market. Hence, regulations such as these would keep a check on manufacturers of cancer diagnostics devices.

Major players in the market are Abbott, Becton Dickinson and Company , Hoffmann-La Roche Ltd, GE Healthcare Ltd., Thermo Fisher Scientific

    1. Executive Summary

    2. Cancer Diagnostics Market Characteristics

    3. Cancer Diagnostics Market Size And Growth

    3.1. Global Cancer Diagnostics Historic Market, 2014 - 2018, $ Billion

    3.1.1. Drivers Of The Market

    3.1.2. Restraints On The Market

    3.2. Global Cancer Diagnostics Forecast Market, 2018 - 2022F, 2025F, 2030F, $ Billion

    3.2.1. Drivers Of The Market

    3.2.2. Restraints On the Market

    4. Cancer Diagnostics Market Segmentation

    4.1. Global Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Companion diagnostics

    Molecular diagnostics

    4.2. Global Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Cancer Research Institutes

    Diagnostic Laboratories

    Hospitals

    Others

    4.3. Global Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Biopsy

    Endoscopy

    Tumor Biomarker Tests

    Imaging

    4.4. Global Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    Cervical Cancer

    Breast Cancer

    Liver Cancer

    Blood Cancer

    Kidney Cancer

    Colorectal Cancer

    Pancreatic Cancer

    Ovarian Cancer

    Melanoma

    Others

    5. Cancer Diagnostics Market Regional And Country Analysis

    5.1. Global Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    5.2. Global Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6. Asia-Pacific Cancer Diagnostics Market  

    6.1. Asia-Pacific Cancer Diagnostics Market Overview  

    6.2. Asia-Pacific Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.3. Asia-Pacific Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    6.4. Asia-Pacific Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    7. China Cancer Diagnostics Market  

    7.1. China Cancer Diagnostics Market Overview  

    7.2. China Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.3. China Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    7.4. China Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F,$ Billion

    8. India Cancer Diagnostics Market  

    8.1. India Cancer Diagnostics Market Overview  

    8.2. India Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.3. India Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    8.4. India Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9. Japan Cancer Diagnostics Market  

    9.1. Japan Cancer Diagnostics Market Overview  

    9.2. Japan Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.3. Japan Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    9.4. Japan Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10. Australia Cancer Diagnostics Market  

    10.1. Australia Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.2. Australia Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    10.3. Australia Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11. Indonesia Cancer Diagnostics Market  

    11.1. Indonesia Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.2. Indonesia Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    11.3. Indonesia Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12. South Korea Cancer Diagnostics Market  

    12.1. South Korea Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.2. South Korea Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    12.3. South Korea Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13. Western Europe Cancer Diagnostics Market  

    13.1. Western Europe Cancer Diagnostics Market Overview

    13.2. Western Europe Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.3. Western Europe Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    13.4. Western Europe Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14. UK Cancer Diagnostics Market  

    14.1. UK Cancer Diagnostics Market Overview

    14.2. UK Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.3. UK Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    14.4. UK Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15. Germany Cancer Diagnostics Market  

    15.1. Germany Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.2. Germany Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    15.3. Germany Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16. France Cancer Diagnostics Market  

    16.5. France Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.6. France Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    16.7. France Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17. Eastern Europe Cancer Diagnostics Market  

    17.1. Eastern Europe Cancer Diagnostics Market Overview

    17.2. Eastern Europe Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.3. Eastern Europe Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    17.4. Eastern Europe Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18. Russia Cancer Diagnostics Market  

    18.1. Russia Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.2. Russia Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    18.3. Russia Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19. North America Cancer Diagnostics Market  

    19.1. North America Cancer Diagnostics Market Overview

    19.2. North America Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.3. North America Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    19.4. North America Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20. USA Cancer Diagnostics Market  

    20.1. USA Cancer Diagnostics Market Overview

    20.2. USA Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.3. USA Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    20.4. USA Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21. South America Cancer Diagnostics Market  

    21.1. South America Cancer Diagnostics Market Overview

    21.2. South America Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.3. South America Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    21.4. South America Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22. Brazil Cancer Diagnostics Market  

    22.1. Brazil Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.2. Brazil Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    22.3. Brazil Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23. Middle East Cancer Diagnostics Market  

    23.1. Middle East Cancer Diagnostics Market Overview

    23.2. Middle East Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.3. Middle East Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    23.4. Middle East Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24. Africa Cancer Diagnostics Market  

    24.1. Africa Cancer Diagnostics Market Overview

    24.2. Africa Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.3. Africa Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    24.4. Africa Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion

    25. Cancer Diagnostics Market Competitive Landscape And Company Profiles

    25.1. Cancer Diagnostics Market Competitive Landscape

    25.2. Cancer Diagnostics Market Company Profiles

    25.2.1. Abbott

    25.2.1.1. Overview

    25.2.1.2. Products and Services

    25.2.1.3. Strategy

    25.2.1.4. Financial Performance

    25.2.2. Becton Dickinson and Company 

    25.2.2.1. Overview

    25.2.2.2. Products and Services

    25.2.2.3. Strategy

    25.2.2.4. Financial Performance

    25.2.3. Hoffmann-La Roche Ltd

    25.2.3.1. Overview

    25.2.3.2. Products and Services

    25.2.3.3. Strategy

    25.2.3.4. Financial Performance

    25.2.4. GE Healthcare Ltd.

    25.2.4.1. Overview

    25.2.4.2. Products and Services

    25.2.4.3. Strategy

    25.2.4.4. Financial Performance

    25.2.5. Thermo Fisher Scientific

    25.2.5.1. Overview

    25.2.5.2. Products and Services

    25.2.5.3. Strategy

    25.2.5.4. Financial Performance

    26. Key Mergers And Acquisitions In The Cancer Diagnostics Market

    27. Cancer Diagnostics Market Trends And Strategies

    28. Cancer Diagnostics Market Future Outlook and Potential Analysis

    29. Appendix

    29.1. Abbreviations

    29.2. Currencies

    29.3. Research Inquiries

    29.4. The Business Research Company

    29.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Table 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Table 3: Global Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 4: Global Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 5: Global Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 6: Global Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 7: Global Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 8: Global Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 10: Asia-Pacific, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 11: Asia-Pacific, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 12: China, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 13: China, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 14: China, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 15: India, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 16: India, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 17: India, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 18: Japan, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 19: Japan, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 20: Japan, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 21: Australia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 22: Australia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 23: Australia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 24: Indonesia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 25: Indonesia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 26: Indonesia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 27: South Korea, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 28: South Korea, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 29: South Korea, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 30: Western Europe, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 31: Western Europe, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 32: Western Europe, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 33: UK, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 34: UK, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 35: UK, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 36: Germany, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 37: Germany, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 38: Germany, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 39: France, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 40: France, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 41: France, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 42: Eastern Europe, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 43: Eastern Europe, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 44: Eastern Europe, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 45: Russia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 46: Russia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 47: Russia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 48: North America, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 49: North America, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 50: North America, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 51: USA, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 52: USA, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 53: USA, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 54: South America, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 55: South America, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 56: South America, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 57: Brazil, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 58: Brazil, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 59: Brazil, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 60: Middle East, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 61: Middle East, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 62: Middle East, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 63: Africa, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 64: Africa, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 65: Africa, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Table 66: Abbott Financial Performance
  • Table 67: Becton Dickinson and Company  Financial Performance
  • Table 68: Hoffmann-La Roche Ltd Financial Performance
  • Table 69: GE Healthcare Ltd. Financial Performance
  • Table 70: Thermo Fisher Scientific Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2014-2018, $ Billion
  • Figure 2: Global Forecast Market Growth, 2014-2022F, 2025F, 2030F, $ Billion
  • Figure 3: Global Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 4: Global Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 5: Global Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 6: Global Cancer Diagnostics Market, Segmentation By Application, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 7: Global Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 8: Global Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 10: Asia-Pacific, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 11: Asia-Pacific, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 12: China, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 13: China, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 14: China, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 15: India, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 16: India, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 17: India, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 18: Japan, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 19: Japan, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 20: Japan, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 21: Australia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 22: Australia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 23: Australia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 24: Indonesia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 25: Indonesia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 26: Indonesia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 27: South Korea, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 28: South Korea, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 29: South Korea, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 30: Western Europe, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 31: Western Europe, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 32: Western Europe, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 33: UK, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 34: UK, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 35: UK, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 36: Germany, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 37: Germany, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 38: Germany, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 39: France, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 40: France, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 41: France, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 42: Eastern Europe, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 43: Eastern Europe, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 44: Eastern Europe, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 45: Russia, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 46: Russia, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 47: Russia, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 48: North America, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 49: North America, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 50: North America, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 51: USA, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 52: USA, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 53: USA, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 54: South America, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 55: South America, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 56: South America, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 57: Brazil, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 58: Brazil, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 59: Brazil, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 60: Middle East, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 61: Middle East, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 62: Middle East, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 63: Africa, Cancer Diagnostics Market, Segmentation By Products, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 64: Africa, Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 65: Africa, Cancer Diagnostics Market, Segmentation By Method, Historic and Forecast, 2014-2018, 2022F, 2025F, 2030F, $ Billion
  • Figure 66: Abbott Financial Performance
  • Figure 67: Becton Dickinson and Company  Financial Performance
  • Figure 68: Hoffmann-La Roche Ltd Financial Performance
  • Figure 69: GE Healthcare Ltd. Financial Performance
  • Figure 70: Thermo Fisher Scientific Financial Performance
Major Orthopedic Joint Replacement Implants Market Growth Drivers
Emerging Trends In The Minor Orthopedic Implants Replacement Market
The Portable Ultrasound Devices Market Will Continue To See Tremendous Growth Due To Aging Populations And Lifestyle Changes
Mobile X-Ray Devices Are The Largest Segment Of The Portable X-Ray Devices Market
Key Players In The Medical Sensors Market Are Focusing On New Product Developments
The Minor Orthopedic Implants Market Was Driven By The Increased Number Of Advanced Surgical Procedures, Especially For Shoulder Replacements
Increased Healthcare Expenditure Drove The Fetal And Neonatal Monitoring Devices Market
Charge Portable Medical Devices From Wi-Fi In The Air!
Portable Ultrasound Devices Market By Segments (Mobile Ultrasound Devices And Handheld Ultrasound Devices), By End user ( Cardiovascular, Obstetrics / Gynecology, Gastro, Musculoskeletal And Point of Care / Others), By Trends, By Geography - Global Forecasts To 2022
View Report
Portable X-Ray Devices Market By Segmentations (Mobile X-Ray Devices, Handheld X-Ray Devices), By Types (Computed Radiography X-Ray Devices, Digital X-Ray Devices and Analog X-Ray), By Trends, By Geography – Global Forecasts to 2022
View Report
In-Vitro Diagnostics Global Market Report 2019
View Report
Dental Equipment And Supplies Global Market Report 2019
View Report
Ophthalmic Devices Global Market Report 2019
View Report
Diagnostic Equipment Global Market Report 2019
View Report
Cardiovascular Devices Global Market Report 2019
View Report
Hospital Supplies Global Market Report 2019
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)